---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-032511"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T18:03:01.755842+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Treace Medical closes public offering of 5.48M shares, net proceeds ~$107.5M

## Summary
- Offering of 5,476,190 shares (including full overallotment) at $21.00/share to the public.
- Net proceeds of $107.5M after underwriting discounts and estimated offering expenses.
- Underwriters purchased shares at $19.74/share; 90-day lock-up for insiders.
- Underwritten by J.P. Morgan and Morgan Stanley; shelf registration on Form S-3 used.

## SEC filing metadata
- accession: 0001193125-23-032511
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000119312523032511/0001193125-23-032511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000119312523032511/d457581d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-032511
- JSON: https://secwatch.observer/filing/0001193125-23-032511.json
- Plain text: https://secwatch.observer/filing/0001193125-23-032511.txt

## Key facts
- Material Agreements
  TREACE MEDICAL CONCEPTS, INC. entered into Underwriting Agreement with J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC valued at Issuance and sale of 4,761,905 shares of common stock at $21.00 per share to public, underwriters pu (effective 2023-02-07).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
  - Value: Issuance and sale of 4,761,905 shares of common stock at $21.00 per share to public, underwriters pu
  - Effective: 2023-02-07
  source text: On February 7, 2023, Treace Medical Concepts, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, as representatives (the “Representatives”) of the several underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell 4,761,905 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (“Common Stock”), to the Underwriters (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630627/000119312523032511/0001193125-23-032511-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.